Medical News

RSS

Galderma Laboratories' Differin Lotion receives FDA approval

Galderma Laboratories, L.P. today announced the U.S. Food and Drug Administration approval of Differin® (adapalene) Lotion, 0.1%, the first-ever lotion formulation of the well-tolerated retinoid adapalene, for the treatment of acne. Differin Lotion, 0.1% will be available by prescription in April 2010.

22 Mar 2010

Freeslate announces the launch of Core Module automation system

Today, Freeslate, Inc. announced the launch of its third generation Core Module automation system (CM3); designed to optimize workflow integration, it enables scientists to leverage a single automated platform to run a diverse array of laboratory applications.

22 Mar 2010

UFCW members applaud passage of health care reforms

Today, the U.S. House of Representatives passed health care reforms that will better serve all Americans. Thanks to the commitment of President Obama and Democratic Members of Congress, we now have reform legislation that has eluded our nation’s grasp for a century.

22 Mar 2010

EHSI closes funding agreement with Celulas Genetica

Emerging Healthcare Solutions, Inc. announced today that it has closed its funding agreement with Celulas Genetica. EHSI will lock in up to 20% of earnings produced by Celulas Genetica when the agreement is funded in full.

22 Mar 2010

Deborah Heart and Lung Center named Top Work Places 2010 and Best Hospital in New Jersey

Not once, but three times this week, Deborah Heart and Lung Center has been recognized as one of the best places to work and receive care. In three separate competitive reviews, Deborah, a specialty heart, lung, and vascular hospital in Browns Mills, has been recognized as a top workplace and top hospital.

22 Mar 2010

Patient dosing in CyDex Pharmaceuticals' Phase 2A clinical trial of CDX-353 initiated

CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company’s Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.

22 Mar 2010

ClaimTrust's new RAC Resource Center opened

ClaimTrust®, a leading provider of revenue cycle tools and services for hospitals, today announced its new Recovery Audit Contractor Resource Center, which will provide hospitals with useful resources, information and tips that will help them prepare staff and infrastructure for RAC record requests, demand letters and appeals.

22 Mar 2010

Over one-third of people with terminal cancer do not receive entitled benefits: Study

Over one-third of people with terminal cancer are not getting the benefits to which they are entitled, a study by Macmillan Cancer Support has found.

22 Mar 2010

Baxa releases DoseEdge Pharmacy Workflow Management System

Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations and increase patient safety, today announced the release of new features for its DoseEdge Pharmacy Workflow Management System. The upgrades extend DoseEdge capabilities to include mobile dose tracking, more pharmacist verification options and enhanced dose status monitoring.

22 Mar 2010

Alliance Imaging to offer mobile PEM imaging services in the state of Florida

Naviscan announced today that Alliance Imaging, a division of Alliance Healthcare Services, will be offering mobile Positron Emission Mammography imaging services in the state of Florida. Alliance Imaging will be providing turnkey service which includes transporting the PEM scanner from site to site, a technologist to perform the scan and the necessary radiopharmaceutical, 18F-FDG.

22 Mar 2010

Two scientific poster presentations on InVision-Plus connectors featured at SHEA meeting

Two scientific poster presentations that demonstrate the infection prevention capabilities of InVision-Plus® with Neutral Advantage™ technology were featured at the annual conference of the Society for Healthcare Epidemiology of America.

22 Mar 2010

Rexahn Pharmaceuticals forms Parkinson’s Disease SAB to develop strategy for Serdaxin

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the formation of its Parkinson’s Disease Scientific Advisory Board (SAB), featuring some of the leading medical researchers in neurology.

22 Mar 2010

SeeChange Health launches first health insurance company in California

SeeChange Health today launched the first new value-based health insurance company in California, offering personalized, value-based health plans that provide incentives to encourage individuals to play an active role in their health management and improve their quality of life. As the first value-based health insurance company to launch in the United States, SeeChange Health brings affordable, next-generation insurance designs to the employer group market.

22 Mar 2010

Decision Resources forecasts multiple myeloma drug market to more than double from $2.1B in 2008 to $5.3B in 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the multiple myeloma drug market will more than double from $2.1 billion in 2008 to $5.3 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

22 Mar 2010

SensAble Technologies to showcase PHANTOM haptic devices at Haptics Symposium

SensAble Technologies, Inc®, a leading provider of haptic devices, 3D modeling software, and dental CAD/CAM solutions, is showcasing a wide range of haptically-enabled computer applications using its industry-leading PHANTOM® haptic devices, at the 18th Haptics Symposium starting Thursday, March 25th.

22 Mar 2010

St. George Investments agrees to withdraw candidates from UAHC Board

United American Healthcare Corporation today announced that the Company has entered into an agreement with St. George Investments, LLC, under which St. George has agreed to withdraw its own slate of candidates for the UAHC Board of Directors and vote in favor of the candidates nominated by UAHC's Board at the Annual Meeting of Shareholders scheduled to be held on April 23, 2010.

22 Mar 2010

OSI Pharmaceuticals to redeem outstanding 3.25% Convertible Senior Subordinated Notes due 2023

OSI Pharmaceuticals, Inc. will fully redeem on April 21, 2010 all of its remaining outstanding 3.25% Convertible Senior Subordinated Notes due 2023 pursuant to the terms of the indenture under which the Notes were issued in September 2003. The aggregate principal amount currently outstanding of the Notes is $60,467,000. The CUSIP number for these Notes is 671040 AD 5.

22 Mar 2010

USW applauds U.S. House of Representatives' historic vote for health insurance reform

The United Steelworkers today applauded the historic vote by the U.S. House of Representatives to pass health insurance reform and called on the Senate to act swiftly on the corrections legislation that will help millions of Americans.

22 Mar 2010

Noveko, AMD-Ritmed announce distribution agreement for Microban hand sanitizers

Noveko International Inc. is pleased to announce that its subsidiary Noveko Inc. has entered into a distribution agreement with AMD-Ritmed Inc., a North American leader in the development and distribution of specialized high-quality and disposable medical supplies.

22 Mar 2010

PharmAthene to provide update on contract modification suspension

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that in addition to its year end results, it will provide an update on the contract modification suspension it received on Friday, March 19, 2010.

22 Mar 2010

Medical News

Galderma Laboratories' Differin Lotion receives FDA approval

Freeslate announces the launch of Core Module automation system

UFCW members applaud passage of health care reforms

EHSI closes funding agreement with Celulas Genetica

Deborah Heart and Lung Center named Top Work Places 2010 and Best Hospital in New Jersey

Patient dosing in CyDex Pharmaceuticals' Phase 2A clinical trial of CDX-353 initiated

ClaimTrust's new RAC Resource Center opened

Over one-third of people with terminal cancer do not receive entitled benefits: Study

Baxa releases DoseEdge Pharmacy Workflow Management System

Alliance Imaging to offer mobile PEM imaging services in the state of Florida

Two scientific poster presentations on InVision-Plus connectors featured at SHEA meeting

Rexahn Pharmaceuticals forms Parkinson’s Disease SAB to develop strategy for Serdaxin

SeeChange Health launches first health insurance company in California

Decision Resources forecasts multiple myeloma drug market to more than double from $2.1B in 2008 to $5.3B in 2018

SensAble Technologies to showcase PHANTOM haptic devices at Haptics Symposium

St. George Investments agrees to withdraw candidates from UAHC Board

OSI Pharmaceuticals to redeem outstanding 3.25% Convertible Senior Subordinated Notes due 2023

USW applauds U.S. House of Representatives' historic vote for health insurance reform

Noveko, AMD-Ritmed announce distribution agreement for Microban hand sanitizers

PharmAthene to provide update on contract modification suspension

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News